The National Primary Health Care Development Agency (NPHCDA) says it has officially ended the country’s first phase of COVID-19 vaccination, adding that the Oxford-AstraZeneca vaccine is 88 per cent portent against the Delta variant detected in the country. The News Agency Of Nigeria (NAN) reports that Nigeria received the first consignment of about 3.92 million doses of the Oxford-AstraZeneca COVID-19 vaccine on March 2, 2021 through the COVID-19 Vaccines Global Assess Facility (COVAX). “It is important to stress that anyone who is 18 years and above is eligible to take the COVID-19 vaccine, including pregnant and lactating women. The Delta variant is the most contagious version of the coronavirus worldwide.”xHe urged Nigerians to stay safe because a large portion of the country remained unvaccinated. Representative of UNICEF in Nigeria, Dr Peter Hawkins, said that COVID-19 vaccines were the most important tool the world had against the virus as thousands of lives had already been saved because of the vaccines.

Source: The Guardian July 13, 2021 19:30 UTC